Monday, June 17, 2019America's Leading Online Business Magazine

ABJ Newsmakers

Apellis Pharmaceuticals Presents Data from Ongoing APL-2 Phase 2 Study in Patients with Cold Agglutinin Disease and Warm Antibody Autoimmune Hemolytic Anemia at 24th European Hematology Association (EHA) Congress

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Indivior, Boston Scientific, KushCo, and Nabriva and Encourages Investors to Contact the Firm

page  30  of  198